DIA Europe 2019

Component Type: Session
Level: Intermediate

Drug repurposing is the process of identifying new uses for existing medicines in indications outside the scope of the original approved product information. Drug repurposing constitutes a dynamic field of drug development that can offer real benefits to patients. More and more stakeholders are involved in the debate on how repurposing can be best enabled, including academics, patients groups, the European Commission and the pharmaceutical industry. Local initiatives in some countries such as the UK have started to identify possible frameworks to improve access to repurposed medicines for patients. Using case studies, this session will present in an interactive manner what repurposing can be in practice, and the roles the various stakeholders can play. Attendees will get a better understanding of the key aspects that must be taken into consideration to enable repurposing in ways which benefit patients with medicines supported with robust data.

Chair

Sheuli Porkess, MD, MRCP, FFPM